Our previous studies have shown that LPA-LPAR activation or mutational activation of GNAi2/gip2 stimulates proliferation, EMT, invasive migration, and metabolic reprogramming of ovarian cancer cells [9,16,17,18,19]. This evidence concerns the gene GNAI2 and ovarian carcinoma.